Skip to main content

ORIGINAL RESEARCH

Pathol. Oncol. Res., 29 April 2021
Volume 27 - 2021 | https://doi.org/10.3389/pore.2021.1609761

MiR-543 Inhibits the Migration and Epithelial-To-Mesenchymal Transition of TGF-β-Treated Endometrial Stromal Cells via the MAPK and Wnt/β-Catenin Signaling Pathways

Linlin Wang,Linlin Wang1,2Dan Liu,,Dan Liu1,3,4Jun Wei Jun Wei1*Liwei Yuan,Liwei Yuan1,3Shiyun Zhao,Shiyun Zhao1,3Yani Huang,Yani Huang1,3Jingwen MaJingwen Ma3Zhijuan YangZhijuan Yang3
  • 1College of Clinical Medicine, Ningxia Medical University, Yinchuan, China
  • 2Medical Experimental Center, General Hospital of Ningxia Medical University, Yinchuan, China
  • 3Department of Gynecology, General Hospital of Ningxia Medical University, Yinchuan, China
  • 4Key Laboratory of Ministry of Education for Fertility Preservation and Maintenance, Ningxia Medical University, Yinchuan, China
This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Wang L, Liu D, Wei J, Yuan L, Zhao S, Huang Y, Ma J and Yang Z (2021) MiR-543 Inhibits the Migration and Epithelial-To-Mesenchymal Transition of TGF-β-Treated Endometrial Stromal Cells via the MAPK and Wnt/β-Catenin Signaling Pathways. Pathol. Oncol. Res. 27:1609761. doi: 10.3389/pore.2021.1609761

Received: 28 January 2021; Accepted: 07 April 2021;
Published: 29 April 2021; Retracted: 25 May 2023.

Edited by:

Anna Sebestyén, Semmelweis University, Hungary

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.